Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEMOTRAD01
2024-511862-35-00Phase 2Authorised
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2024
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of temozolomide in brainstem glioma, sponsored by Assistance publique - Hôpitaux de Paris. Planned start Aug 2024; status: authorised.
02
Drugs
temozolomide
03
Conditions
brainstem glioma
Beyond the preview
Go deeper on 2024-511862-35-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511862-35-00.